Biogen Lowers FY2026 Adj EPS Guidance from $14.25-$15.25 to $12.00-$13.00 vs $12.83 Est

Benzinga Newsdesk www.benzinga.com Negative 95.7%

Neg 95.7% Neu 0% Pos 0%

Biogen (NASDAQ:BIIB) lowers FY2026 Adj EPS guidance from $14.25-$15.25 to $12.00-$13.00 vs $12.83 analyst estimate..

Comments

No comments yet. Be the first!